
Moderna Inc's Covid-19 vaccine is effective in children and adolescents, with mostly mild to moderate side effects, the United States Food and Drug Administration staff said.
“Available data support the effectiveness of the Moderna Covid-19 vaccine in preventing symptomatic Covid-19 in paediatric age groups from 6 months through 17 years of age,” the FDA staff said Friday in the report posted to the agency’s website. Side effects were “mostly mild to moderate in severity, generally of short duration.”